Tofacitinib reduced death or respiratory failure at 28 d in patients hospitalized with COVID-19 pneumonia. Tong SYC, Petersiel N. Ann Intern Med 2021 Oct 5. doi: 10.7326/ACPJ202110190.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tong SYC, Petersiel N. Tofacitinib reduced death or respiratory failure at 28 d in patients hospitalized with COVID-19 pneumonia. Ann Intern Med 2021 Oct 5. doi: 10.7326/ACPJ202110190.
PMID: 34606317